MedBIKE HIIT for Congenital Heart Disease

University of Alberta, Edmonton, Canada
Congenital Heart Disease+1 More ConditionsMedBIKE HIIT - Device
10 - 18
All Sexes
What conditions do you have?

Study Summary

This trial will study the effects of a home-based high intensity interval training program on exercise capacity in adolescents with repaired congenital heart disease.

Eligible Conditions
  • Congenital Heart Disease
  • Acute Lymphoblastic Leukemia (ALL) in Children.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention

Baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention
Changes in Health-Related Quality of Life as measured using the TNO AZL Children's Quality of Life (TACQOL) questionnaire.
Changes in endothelial function to determine arterial volume will be measured using an EndoPAT 2000 instrument.
Changes in physical activity, defined as time spent in moderate to vigorous physical activity (MVPA) and sedentary time, measured by wearing an accelerometer for 7-days prior and 7-days post MedBIKE intervention
Changes in self efficacy towards physical activity measured on the Children's Self-Perceptions of Adequacy in and Predilection for Physical Activity (CSAPPA) scale.
Exercise capacity in the change in VO2peak (mL/kg/min) measured through CPET testing

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

44 Total Participants · 1 Treatment Group

Primary Treatment: MedBIKE HIIT · No Placebo Group · N/A

Experimental Group · 1 Intervention: MedBIKE HIIT · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention

Who is running the clinical trial?

Heart and Stroke Foundation of CanadaOTHER
118 Previous Clinical Trials
70,726 Total Patients Enrolled
University of AlbertaLead Sponsor
839 Previous Clinical Trials
386,772 Total Patients Enrolled
Michael Khoury, MDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
10 Total Patients Enrolled

Eligibility Criteria

Age 10 - 18 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The study is not open to children under 10 years of age or adults over 18 years of age.
You have a heart condition that was treated when you were born, but it was not too severe.

Frequently Asked Questions

How many enrollees are participating in this experiment?

"Affirmative. Records on verify that this medical study, first advertised on November 22nd 2022, is currently accepting participants. Approximately 44 individuals are sought from one healthcare facility." - Anonymous Online Contributor

Unverified Answer

Is this experiment currently seeking participants?

"Indeed, data hosted on corroborates that this medical experiment is actively searching for participants. This trial was first posted on November 22nd 2022 and has been updated recently on the 25th of November 2022 with a demand for 44 patients from 1 location." - Anonymous Online Contributor

Unverified Answer

Might I qualify for participation in this medical experiment?

"This experiment calls for 44 participants between the ages of 10 and 18 who are suffering from congenital heart disease (CHD)." - Anonymous Online Contributor

Unverified Answer

Does the research include geriatric participants?

"Patients that meet the standards of this medical study must be between 10 and 18 years old. There are 120 trials open to minors, while a total of 273 clinical trails accept seniors over 65." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.